We are live on ! Find out more
First Trust Advisors

First Trust Advisors Portfolio holdings

AUM $140B
1-Year Est. Return 27.84%
This Fund
S&P 500
This Quarter Est. Return
+5.76%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$24.1B
AUM Growth
+$1.31B
Cap. Flow
+$207M
Cap. Flow %
0.86%
Top 10 Hldgs %
6.52%
Holding
2,393
New
154
Increased
1,057
Reduced
989
Closed
188

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$53.3M
2
PM icon
Philip Morris
PM
+$50.2M
3
BF.B icon
Brown-Forman Class B
BF.B
+$46.9M
4
GMCR
KEURIG GREEN MTN INC
GMCR
+$45.5M
5
FBT icon
First Trust NYSE Arca Biotechnology Index Fund
FBT
+$45.2M

Top Sells

Rank Stock Value
1
EPD icon
Enterprise Products Partners
EPD
+$142M
2
EEP
Enbridge Energy Partners
EEP
+$94.6M
3
MRK icon
Merck
MRK
+$70M
4
KMR
KINDER MORGAN MANAGEMENT LLC
KMR
+$68.7M
5
MMP
Magellan Midstream Partners, L.P.
MMP
+$56.5M

Sector Composition

Rank Sector Weight
1 Healthcare 15.85%
2 Technology 12.34%
3 Industrials 9.86%
4 Consumer Discretionary 9.64%
5 Energy 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DGX icon
51
Quest Diagnostics
DGX
$25.1B
$65.4M 0.27%
1,113,658
+41,687
+4% +$2.44M
EXPE icon
52
Expedia Group
EXPE
$31.2B
$65.4M 0.27%
829,804
-122,466
-13% -$8.92M
APA icon
53
APA Corp
APA
$12.8B
$64.5M 0.27%
641,330
+126,264
+25% +$11.4M
IBM icon
54
IBM
IBM
$202B
$64.5M 0.27%
372,207
+87,401
+31% +$15.7M
FXG icon
55
First Trust Consumer Staples AlphaDEX Fund
FXG
$231M
$64.4M 0.27%
1,617,052
+1,090,676
+207% +$41.4M
ELV icon
56
Elevance Health
ELV
$81.9B
$64.3M 0.27%
597,804
+30,415
+5% +$3.13M
LO
57
DELISTED
LORILLARD INC COM STK
LO
$62.3M 0.26%
1,021,770
+370,032
+57% +$21.5M
LNKD
58
DELISTED
LinkedIn Corporation
LNKD
$62M 0.26%
361,630
-63,704
-15% -$10.3M
FXD icon
59
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$263M
$62M 0.26%
1,863,611
+1,257,012
+207% +$40.1M
KR icon
60
Kroger
KR
$34.8B
$61.9M 0.26%
2,504,034
+1,099,026
+78% +$25.6M
SLXP
61
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$60.5M 0.25%
490,738
-26,661
-5% -$2.95M
BMRN icon
62
BioMarin Pharmaceuticals
BMRN
$11.5B
$58.9M 0.24%
947,273
+35,990
+4% +$2.17M
PM icon
63
Philip Morris
PM
$301B
$58.8M 0.24%
697,145
+582,790
+510% +$50.2M
AGN
64
DELISTED
Allergan plc
AGN
$58.7M 0.24%
263,142
-26,935
-9% -$5.58M
VTRS icon
65
Viatris
VTRS
$20.1B
$57.7M 0.24%
1,119,453
-74,306
-6% -$3.65M
CPHD
66
DELISTED
Cepheid Inc
CPHD
$57.7M 0.24%
1,202,871
-2,086
-0.2% -$94.6K
PCYC
67
DELISTED
PHARMACYCLICS INC
PCYC
$57.6M 0.24%
642,279
+71,125
+12% +$6.67M
AET
68
DELISTED
Aetna Inc
AET
$57.2M 0.24%
706,081
+127,665
+22% +$9.66M
BF.B icon
69
Brown-Forman Class B
BF.B
$12B
$56.8M 0.24%
1,885,844
+1,604,528
+570% +$46.9M
MCK icon
70
McKesson
MCK
$98.5B
$56.8M 0.24%
305,131
+610
+0.2% +$109K
TEG
71
DELISTED
INTEGRYS ENERGY GROUP INC COM (USA)
TEG
$56.7M 0.24%
797,073
+291,606
+58% +$17.5M
GM icon
72
General Motors
GM
$74.7B
$56.2M 0.23%
1,547,593
+139,349
+10% +$4.86M
DUK icon
73
Duke Energy
DUK
$102B
$56.2M 0.23%
756,866
+197,316
+35% +$14.2M
DVA icon
74
DaVita
DVA
$15.1B
$55.7M 0.23%
770,697
+465,316
+152% +$32.4M
CVS icon
75
CVS Health
CVS
$137B
$55.7M 0.23%
738,935
+93,764
+15% +$7.09M
1 2
3
4 5

Similar funds

DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
National Pension Service
National Pension Service Jeonju-Si, Jeollabuk-Do, South Korea $132B AUM 28.96% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

First Trust Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, First Trust Advisors held 2,393 positions worth $24.1B, up 5.8% from $22.8B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

First Trust Advisors's Q2 2014 filing shows 154 new, 1,057 increased, 989 reduced and 188 closed positions. Its largest new stake was Brookdale Senior Living: 1,010,257 shares worth $33.7M. The largest sale was Enterprise Products Partners, an estimated $142M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

  • First Trust Advisors's largest Q2 2014 buy was Brookdale Senior Living: 1,010,257 shares worth $33.7M.
  • First Trust Advisors added most to Pfizer in Q2 2014, an estimated $53.3M increase.
  • First Trust Advisors's biggest Q2 2014 reduction was Enterprise Products Partners, cutting an estimated $142M.
  • First Trust Advisors fully exited KINDER MORGAN MANAGEMENT LLC in Q2 2014, selling an estimated $68.7M.
  • First Trust Advisors's ten largest holdings make up 6.5% of its $24.1B portfolio in Q2 2014.
  • First Trust Advisors opened 154 new positions and closed 188 in Q2 2014.
  • First Trust Advisors's portfolio value rose 5.8% quarter-over-quarter to $24.1B.

Based on First Trust Advisors's 13F filing for Q2 2014, filed 11 Aug 2014.